People
VeraSci, a leading provider of innovative scientific and technology services, announced the hire of Hampton Corley, Chief Commercial Officer, to support growth objectives.
Clinical Ink is pleased to announce that Jonathan Andrus, chief business officer at Clinical Ink, has been invited to be a panelist in a public meeting hosted by the Duke-Margolis Center for Health Policy on July 17, 2019, in Washington, D.C. The workshop, convened under a cooperative agreement with the FDA, will discuss opportunities to improve the implementation of risk-based monitoring (RBM) in clinical investigations.
Biotech and pharma companies strengthen their leadership teams and boards with new hires and appointments.
Efforts undertaken by state and local leaders across the five states that make up Pharm Country have led to a boost in business, which is good news for applicants seeking a new position.
Pyrrolobenzodiazepine-based antibody drug conjugates demonstrate potential for the treatment of relapsed or refractory lymphomas as single agents and in combination therapies
Seasoned business executive will bring important insights in licensing strategy and contribute to Domain’s next phase of development
The round brings total financing up to $95 million.
The indictment revolves around several investment projects including the development of a biotech company, AnC Bio Vermont, in Newport, Vermont, and the government’s EB-5 program, which offers permanent U.S. residency in exchange for $500,000 investments in approved businesses that will create specific numbers of jobs.
Vygon Asia announces that it has donated 50 Vygon Polysite ISP implantable ports for patients undergoing chemotherapy at the Mount Miriam Cancer Hospital under the One Port One Life program.
Denis Rebrikov indicates he plans to ask for approval from three government agencies, including Russia’s health ministry. He told Nature that could take anywhere from one month to two years.
PRESS RELEASES